The COVID Reckoning Doesn’t Go Far Enough
The public health establishment lost America’s trust during the COVID-19 pandemic with its bureaucratic incompetence, “noble lies,” and…
Top FDA official seeks to hire friend pushing new antidepressants warning
WASHINGTON (AP) — The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to…
FDA plans bonuses to staffers who complete speedy drug reviews
WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
FDA commissioner’s drug review plan sparks alarm
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored…
Top FDA drug regulator plans to depart weeks into job
The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job. Pazdur…
Rick Pazdur to replace George Tidmarsh at FDA drug center
WASHINGTON (AP) — The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to…
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’
WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal…
FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz
WASHINGTON – For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions…